Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse
暂无分享,去创建一个
F. Sigaux | J. Soulier | E. Clappier | A. Baruchel | F. Pflumio | M. Delord | P. Ballerini | L. Hernandez | B. Gerby | Farah Touzri
[1] Leslie L Robison,et al. Acute lymphoblastic leukaemia , 2018, Radiopaedia.org.
[2] S. Hunger,et al. Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group. , 2011, Blood.
[3] K. Anderson,et al. Genetic variegation of clonal architecture and propagating cells in leukaemia , 2011, Nature.
[4] I. Bernstein,et al. Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activity , 2010, Leukemia.
[5] F. Staal,et al. Genome-wide expression analysis of paired diagnosis–relapse samples in ALL indicates involvement of pathways related to DNA replication, cell cycle and DNA repair, independent of immune phenotype , 2010, Leukemia.
[6] A. Ferrando,et al. Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia , 2009, Nature Genetics.
[7] S. Morrison,et al. Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.
[8] A. Ferrando,et al. WT1 mutations in T-ALL. , 2009, Blood.
[9] L. Chin,et al. High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. , 2009, Blood.
[10] H. Dombret,et al. NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity. , 2009, Blood.
[11] J. Dick,et al. Stem cell concepts renew cancer research. , 2008, Blood.
[12] James R. Downing,et al. Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia , 2008, Science.
[13] M. Relling,et al. Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. , 2008, Blood.
[14] R. Pieters,et al. Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemia , 2008, British journal of haematology.
[15] B. Lange,et al. Bone-marrow relapse in paediatric acute lymphoblastic leukaemia. , 2008, The Lancet. Oncology.
[16] E. Raetz,et al. Molecular pathogenesis of T-cell leukaemia and lymphoma , 2008, Nature Reviews Immunology.
[17] Govind Bhagat,et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia , 2007, Nature Medicine.
[18] B. Nadel,et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. , 2007, Blood.
[19] U. Kees,et al. Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone. , 2007, Blood.
[20] Adam A. Margolin,et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth , 2006, Proceedings of the National Academy of Sciences.
[21] R. Spang,et al. Expression of Late Cell Cycle Genes and an Increased Proliferative Capacity Characterize Very Early Relapse of Childhood Acute Lymphoblastic Leukemia , 2006, Clinical Cancer Research.
[22] George Davidson,et al. Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. , 2006, Blood.
[23] S. Morrison,et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells , 2006, Nature.
[24] F. Sigaux,et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). , 2005, Blood.
[25] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[26] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[27] M. Greaves,et al. TEL Deletion Analysis Supports a Novel View of Relapse in Childhood Acute Lymphoblastic Leukemia , 2004, Clinical Cancer Research.
[28] E. Lander,et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.
[29] R. Pieters,et al. In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. , 1995, Blood.
[30] Irving L. Weissman,et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271 , 2011, Nature.
[31] A. Ferrando,et al. WT 1 mutations in TALL , 2009 .
[32] Iannis Aifantis,et al. γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia , 2009, Nature Medicine.
[33] P. Marynen,et al. Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. , 2005, Haematologica.